NCT05671835 Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT05657184 Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001 Status COMPLETED Phase PHASE1
NCT05621252 Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) Status COMPLETED Phase PHASE2
NCT05571059 Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status RECRUITING Phase PHASE2
NCT05537025 Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT05513950 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD). Status COMPLETED Phase PHASE1
NCT05497284 To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF Status TERMINATED Phase PHASE2
NCT05483907 To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF Status COMPLETED Phase PHASE2
NCT05468502 Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1
NCT05449431 Comparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary Fibrosis Status UNKNOWN Phase NA
NCT05428150 Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05427253 First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05424887 A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase PHASE2
NCT05389215 Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF Status RECRUITING Phase PHASE2
NCT05383131 To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05373914 RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status UNKNOWN Phase PHASE2
NCT05366387 Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase NA